Guidance for completing the Drug Submission Application Form (English, HTML)

View metadata and access the original English HTML file: Guidance for completing the Drug Submission Application Form.

Format

HTML

Access

file-only

Publisher-reported update

2023-09-01

For Drug Identification Number applications, a separate completed HC/SC 3011 must be provided for each formulation, strength and dosage form. For all other submission types, only a separate completed Part 2 must be provided for each formulation, strength and dosage form.

Access original file